Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India

References

• Abraham, K. K., D'Costa, C., Shunmugam, M., & Chakrapani, V. (2007). India. In International Treatment Preparedness Coalition (ITPC) (Ed.), Missing the target #5: Improving AIDS drug access and advancing health care for all (pp. 75–76). San Francisco, CA: The Tides Center. Retrieved from http://www.opensocietyfoundations.org/sites/default/files/missing_20071201.pdf
   Google Scholar
• Aceijas, C., Oppenheimer, E., Stimson, G. V., Ashcroft, R. E., Matic, S., & Hickman, M. (2006). Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the “Treating 3 million by 2005. Making it happen. The WHO strategy” (“3 by 5”). Addiction, 101, 1246–1253. doi:10.1111/j.1360-0443.2006.01509.x
   PubMed Web of Science ®Google Scholar
• Aday, L. A., & Andersen, R. (1974). A framework for the study of access to medical care. Health Services Research, 9, 208–220.
   PubMedGoogle Scholar
• Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., & Moss, A. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435–442.
   PubMed Web of Science ®Google Scholar
• Bassetti, S., Battegay, M., Furrer, H., Rickenbach, M., Flepp, M., Kaiser, L., … Sudre, P. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 21, 114–119.
   PubMed Web of Science ®Google Scholar
• Chakrapani, V. (2005). India. In International Treatment Preparedness Coalition (ITPC) (Ed.), Missing the target #1: A report on HIV/AIDS treatment access from the frontlines (pp. 25–38). Cape Town: ITPC. Retrieved from http://www.hivpolicy.org/Library/HPP001289.pdf
   Google Scholar
• Chakrapani, V., Newman, P. A., Shunmugam, M., & Dubrow, R. (2011). Barriers to free antiretroviral treatment access among kothi-identified men who have sex with men and aravanis (transgender women) in Chennai, India. AIDS Care, 23, 1687–1694. doi:10.1080/09540121.2011.582076
   PubMed Web of Science ®Google Scholar
• Chakrapani, V., Newman, P. A., Shunmugam, M., Kurian, A. K., & Dubrow, R. (2009). Barriers to free antiretroviral treatment access for female sex workers in Chennai, India. AIDS Patient Care and STDs, 23, 973–980. doi:10.1089/apc.2009.0035
   PubMed Web of Science ®Google Scholar
• Charmaz, K. (2006). Constructing grounded theory: A practical guide through qualitative analysis. Thousand Oaks, CA: Sage.
   Google Scholar
• Clarke, S., Delamere, S., McCullough, L., Hopkins, S., Bergin, C., & Mulcahy, F. (2003). Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Medicine, 4(1), 33–37. doi:10.1046/j.1468-1293.2003.00130.x
   PubMedGoogle Scholar
• Ding, L., Landon, B. E., Wilson, I. B., Wong, M. D., Shapiro, M. F., & Cleary, P. D. (2005). Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Archives of Internal Medicine, 165, 618–623. doi:10.1001/archinte.165.6.618
   PubMed Web of Science ®Google Scholar
• Escaffre, N., Morin, M., Bouhnik, A. D., Fuzibet, J. G., Gastaut, J. A., Obadia, Y., & Moati, J. P. (2000). Injecting drug users' adherence to HIV antiretroviral treatments: Physicians' beliefs. AIDS Care, 12, 723–730. doi:10.1080/09540120020014264
   PubMed Web of Science ®Google Scholar
• Gebo, K. A., Keruly, J., & Moore, R. D. (2003). Association of social stress, illicit drug use, and health beliefs with non-adherence to antiretroviral therapy. Journal of General Internal Medicine, 18(2), 104–111. doi:10.1046/j.1525-1497.2003.10801.x
   PubMed Web of Science ®Google Scholar
• Kerr, T., Marshall, A., Walsh, J., Palepu, A., Tyndall, M., Montaner, J., … Wood, E. (2005). Determinants of HAART discontinuation among injection drug users. AIDS Care, 17, 539–549. doi:10.1080/09540120412331319778
   PubMed Web of Science ®Google Scholar
• Knowlton, A., Arnsten, J., Eldred, L., Wilkinson, J., Gourevitch, M., Shade, S., … INSPIRE Team. (2006). Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. Journal of Acquired Immune Deficiency Syndromes, 41, 486–492. doi:10.1097/01.qai.0000186392.26334.e3
   PubMed Web of Science ®Google Scholar
• Kumar, M. S., & Agrawal, A. (2012). Scale-up of opioid substitution therapy in India: Opportunities and challenges. International Journal of Drug Policy, 23, 169–170. doi:10.1016/j.drugpo.2011.11.002
   PubMed Web of Science ®Google Scholar
• Latkin, C., Srikrishnan, A. K., Yang, C., Johnson, S., Solomon, S. S., Kumar, S., … Solomon, S. (2010). The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India. Drug and Alcohol Dependence, 110, 221–227. doi:10.1016/j.drugalcdep.2010.03.004
   PubMed Web of Science ®Google Scholar
• Lincoln, Y. S., & Guba, E. (1985). Naturalistic enquiry. Newbury Park, CA: Sage.
   Google Scholar
• Maisels, L., Steinberg, J., & Tobias, C. (2001). An investigation of why eligible patients do not receive HAART. AIDS Patient Care and STDs, 15, 185–191. doi:10.1089/10872910151133701
   PubMed Web of Science ®Google Scholar
• Moatti, J. P., Carrieri, M. P., Spire, B., Gastaut, J. A., Cassuto, J. P., & Moreau, J. (2000). Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS, 14, 151–155. doi:10.1097/00002030-200001280-00010
   PubMed Web of Science ®Google Scholar
• National AIDS Control Organization [NACO]. (2006). Strategy and implementation plan – National AIDS Control Programme Phase III [2007–2012]. New Delhi: Ministry of Health and Family Welfare, Government of India.
   Google Scholar
• National AIDS Control Organization [NACO]. (2008). Standard operating procedure for oral substitution therapy with buprenorphine. New Delhi: Ministry of Health and Family Welfare, Government of India.
   Google Scholar
• National AIDS Control Organization [NACO]. (2012). India Report NCPI [National Commitments and Policies Instrument]. Retrieved from http://www.unaids.org/en/dataanalysis/knowyourresponse/ncpi/2012countries/India%20NCPI%202012.pdf
   Google Scholar
• Rao, R., Agrawal, A., Kishore, K., & Ambekar, A. (2013). Delivery models of opioid agonist maintenance treatment in South Asia: A good beginning. Bulletin of World Health Organisation, 91, 150–153. doi:10.2471/BLT.12.111815
   PubMed Web of Science ®Google Scholar
• Ritchie, J., & Spencer, E. (1994). Qualitative data analysis for applied policy research. In A. Bryman & R. G. Burgess (Eds.), Analyzing qualitative data (pp. 173–194). London: Routledge.
   Google Scholar
• Sambamoorthi, U., Warner, L. A., Crystal, S., & Walkup, J. (2000). Drug abuse, methadone treatment, and health services use among injection drug users with AIDS. Drug and Alcohol Dependence, 60, 77–89.
   PubMed Web of Science ®Google Scholar
• Sharma, M., Singh, R. R., Laishram, P., Kumar, B., Nanao, H., Sharma, C., & Ahmed, T. (2007). Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): An initial assessment. International Journal of Drug Policy, 18, 319–325. doi:10.1016/j.drugpo.2007.04.001
   PubMed Web of Science ®Google Scholar
• Solomon, S. S., Srikrishnan, A. K., Mehta, S. H., Vasudevan, C. K., Murugavel, K. G., Thamburaj, E., … Celentano, D. D. (2008). High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: A cause for concern. Journal of Acquired Immune Deficiency Syndromes, 49, 327–332. doi:10.1097/QAI.0b013e3181831e85
   PubMed Web of Science ®Google Scholar
• Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks, CA: Sage.
   Google Scholar
• Wainberg, F. M. A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279, 1977–1983. doi:10.1001/jama.279.24.1977
   PubMed Web of Science ®Google Scholar
• Wolfe, D. (2007). Paradoxes in antiretroviral treatment for injecting drug users: Access, adherence and structural barriers in Asia and the former Soviet Union. International Journal of Drug Policy, 18, 246–254. doi:10.1016/j.drugpo.2007.01.012
   PubMed Web of Science ®Google Scholar
• Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376, 355–366. doi:10.1016/S0140-6736(10)60832-X
   PubMed Web of Science ®Google Scholar
• Wood, E., Hogg, R. S., Kerr, T., Palepu, A., Zhang, R., & Montaner, J. S. (2005). Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users. AIDS, 19, 837–839. doi:10.1097/01.aids.0000168982.20456.eb
   PubMed Web of Science ®Google Scholar
• Wood, E., Kerr, T., Tyndall, M. W., & Montaner, J. S. (2008). A review of barriers and facilitators of HIV treatment among injection drug users. AIDS, 22, 1247–1256. doi:10.1097/QAD.0b013e3282fbd1ed
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2004). Guidance on ethics and equitable access to HIV treatment and care. Geneva: Author.
   Google Scholar
• World Health Organization Regional Office for Europe. (2007). HIV/AIDS treatment and care for injecting drug users. Clinical protocol for the WHO European region. Copenhagen: Author.
   Google Scholar